Transaction Details

Footnotes

The price reported represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $74.17 to $74.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | Includes acquisition of 25.3808 shares pursuant to dividend reinvestment. | The options became fully exercisable on April 4, 2025, the third anniversary of the grant date. | One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025, and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.